A Study for the investigation of symptomatic improvement and safety of INJUV ingestion in individuals with knee and low back pai

Not Applicable

• Conditions: /A (healthy adults)

• Registration Number: JPRN-UMIN000026460
• Lead Sponsor: Anti-Aging Bank Co.,Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-03-10
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Not provided

Exclusion Criteria

[1]Individuals receiving medical drugs for treatment of chronic diseases [2]Individuals receiving outpatient care (except for bonesetters, chiropractors, massagers) for knee and/or low back pain [3]Individuals with history of palliative therapy (hyaluronic acid, steroid injection, etc.) or surgical therapy (arthroscopic osteotomy, artificial joint, bolt fixation surgery, etc.)on knees and/or waist [4]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders [5]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. [6]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) [7]Individuals with history of gastrointestinal disorders except for appendicitis [8]Individuals with inflammatory disorders such as chronic sinusitis, periodontal disease, bronchitis, etc. [9]Individuals with >=30.0kg/m2 BMI [10]Individuals donated blood >200ml in past 1 month or >400ml in past 3 months [11]Individuals with serious anemia [12]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs [13]Individuals continually consumed health foods that may interfere the study results (especially glucosamine, chondroitin, etc.) in the past 3 months except for general nutritional supplements [14]Individuals with alcohol intake exceeding 40mg/day,200mg/week as ethanol volume [15]Smokers or ex-smokers within one year after quitting [16]Individuals who may significantly change exercise habit or lifestyle during the study period [17]Individuals participating or planning to join the other clinical investigations during the study period [18]Pregnant or lactating women (expected, desired inclusive) [19]Individual with potential conflict of interests etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified